Trial intelligence / Profile preview

OléograpeSEED in Osteoarthritis

NCT02566798Completed

Sponsor
CHU de Nantes
Start
Dec 2015
Primary completion
Apr 2016
Countries
1
01

Overview

Trial in osteoarthritis (OA) (2 arms), sponsored by CHU de Nantes. Primary endpoints: Nitric Oxide production in cell culture supernatant at 7 days and Prostaglandin E2 production in cell culture supernatant at 7 days. Started Dec 2015; status: completed.

02

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT02566798.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02566798.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call